
Still waiting for a fourth stimulus cheque in July or August? Here's why that $2,000 isn't coming
Tired of too many ads?
Remove Ads
Tired of too many ads?
Remove Ads
IRS and Treasury: No fourth cheque in the works
Trump's DOGE plan still just a proposal
Cost of living rising, relief still sparse
Tired of too many ads?
Remove Ads
Stimulus payment scams and fake forms on the rise
A quick look at past stimulus payments
The first cheque, issued in March-April 2020, provided up to $1,200 for individuals and $2,400 for married couples, plus $500 per qualifying child under 17
The second cheque, sent by January 2021, was up to $600 per person and $600 per dependent
The third cheque, delivered between March and December 2021, gave $1,400 per eligible individual, and $1,400 per dependent
How to track refunds or missing stimulus payments
Over the past week, rumours have surged online about a fourth stimulus cheque worth $2,000 supposedly coming in July or August 2025. These claims, heavily circulated on social media and through loosely sourced articles, suggest that new federal relief is on the way for struggling Americans.But there is no official confirmation. Not from the Internal Revenue Service (IRS), not from the US Congress, and not from the Treasury Department.This wave of misinformation follows a 19 July article by Rick Adams, which implied that lawmakers were considering new payments due to mounting public pressure. The article stated that single filers earning less than $75,000, and married couples earning under $150,000, would qualify. It also mentioned additional amounts for dependents, with direct deposits possibly starting late 2025 or early 2026 if approved.But that 'if' remains very much hypothetical.No draft legislation, budget allocation or public statement supports these claims. The most recent IRS update, IR-2025-75 issued on 15 July, focused on tax security and extensions. It made no mention of new stimulus efforts.There's been no movement from the IRS or the Treasury to suggest that another stimulus is being prepared.The last round of Economic Impact Payments was part of the American Rescue Plan in 2021. That provided up to $1,400 per eligible individual. As of now, the only related payments still being processed involve the 2021 Recovery Rebate Credit, with $2.4 billion in unclaimed funds still being issued. But that process ends by January 2025.The IRS confirmed in bulletin IR-2024-314 that this is not a new cheque, just money left unclaimed from the third stimulus. Congress has not passed any law approving a fourth round. And the deadline to file for the third stimulus expired on 15 April 2025.Back in February, Donald Trump floated the idea of a one-time $5,000 'DOGE dividend' during a summit in Miami. He tied it to projected savings from Elon Musk's Department of Government Efficiency (DOGE).Trump said, 'We are considering using part of the 20% in savings DOGE identified and giving that back to taxpayers.'That proposal, however, has gone nowhere. There's been no follow-up from Congress, no formal plan, and certainly no timeline. It remains just an idea with no structure or funding behind it.There's no denying that many Americans are feeling the pinch. Rising costs of rent, food and healthcare continue to put pressure on households, especially the elderly and low-income earners. Adams noted this in his article, and there is some factual basis to that concern.Social Security's Cost-of-Living Adjustment (COLA) for 2025 aims to provide some support. But it's not keeping pace with actual inflation rates.Economists cited by kiplinger.com calculated that the proposed DOGE savings of $130 billion, even if redistributed, would only amount to around $807 per taxpayer, far below the claimed $2,000. That figure also assumes full congressional approval, which has not been granted.As these rumours spread, so do the scams. Users on X (formerly Twitter) have flagged fake text messages and websites offering early access to the supposed cheque.The IRS is urging caution. In a statement, it advised citizens to 'check irs.gov for updates and avoid unsolicited payment requests.'It's also worth noting that some states have issued their own forms of inflation relief. These are not federal cheques, and the amounts are far smaller.For example, New York sent one-time inflation cheques of $200 for individuals earning up to $75,000, and $400 for married couples earning up to $150,000. Pennsylvania, Georgia and Colorado also issued what they termed 'rebate cheques' to qualifying taxpayers or property owners. Each state uses its own criteria.Let's put the $2,000 rumour into context by looking at the actual stimulus history:Any unclaimed stimulus payments had to be filed for via the 2021 tax return. The final deadline was 15 April 2025, with no extensions available. Even if a taxpayer requested a filing extension, that did not apply to the stimulus claim. The IRS made clear that 'any unclaimed stimulus payments become the property of the U.S. Treasury.'If you are waiting for a tax refund or think you might have missed a stimulus payment, the best step is to use the IRS's 'Where's My Refund' tool online. It updates daily and lets users track the progress of their federal return. You will need your Social Security number, filing status and the exact refund amount to access the tool.If you filed electronically with direct deposit, you can expect to see the refund in your account within 21 days. For paper filers, it might take up to eight weeks.Alternatively, the IRS helpline at 800-829-1954 is available for those unable to use the website.State refunds, meanwhile, must be tracked via each state's own tax portal. For example, the Delaware Division of Taxation and the Pennsylvania Department of Revenue each have dedicated online systems.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)

Business Standard
19 minutes ago
- Business Standard
Donald Trump's tax law to add $3.4 trillion to US deficits, says CBO
President Donald Trump's recently enacted tax and spending law will add $3.4 trillion to US deficits over a decade and leave millions without health care coverage, according to a new estimate from the nonpartisan Congressional Budget Office. The CBO score for the law, released Monday, reflects a $4.5 trillion decrease in revenues and a $1.1 trillion decline in spending through 2034, relative to a current-law baseline. The new analysis doesn't incorporate so-called dynamic effects, such as the impact on growth or interest rates over time that the legislation's measures might have. Trump signed the 'One Big Beautiful Bill' into law on July 4 after months of negotiations with congressional Republicans. Encompassing much of Trump's economic agenda, it permanently extends his 2017 income-tax cuts and some breaks for businesses, lifts the cap on federal deductions for state and local taxes and eliminates taxes on tips and overtime on a temporary basis, among other provisions. Passage of the law triggered warnings from some economists and investors about a widening of America's budget shortfall — already large by historical standards — that could push borrowing costs and inflation up. The Trump administration points to record collections from the tariffs he's imposed on most US imports this year, saying that revenue will help fill the gap. A number of spending cuts were included in the tax law in an effort to reduce deficits and offset the cost, including to Medicaid, which provides health insurance for low-income people. New work requirements for recipients of Medicaid under the age of 65, are set to begin by the end of 2026. The law also limits states' ability to tax health care providers to help fund the program. Provisions in the law will result in 10 million Americans losing health insurance by 2034, according to the CBO analysis. The potential loss of health insurance coverage comes as rising prices due to tariffs already threaten to create increased economic hardship for low-income families. June inflation data showed some signs of the levies' impact on costs and economists expect prices to continue to rise over the summer. This would disproportionately impact low-income Americans as they tend to spend a larger share of their income on necessities, such as food. At the request of Senate Republicans, the bill was also scored separately relative to a current policy baseline. On that basis it would reduce deficits by $366 billion over a decade, with revenues falling $849 billion in the period — about one-fifth of the drop recorded in the conventional scoring. Lawmakers used this accounting maneuver to count the permanent extension of the 2017 income-tax cuts as costing nothing.
&w=3840&q=100)

Business Standard
19 minutes ago
- Business Standard
AstraZeneca unveils $50 bn US investment as pharma tariff threat looms
AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on Monday, the latest big investment by a pharmaceutical company reacting to President Donald Trump's tariff policy. The investment will fund a new drug manufacturing facility in Virginia and expand research and development (R&D) and cell therapy manufacturing in Maryland, Massachusetts, California, Indiana and Texas, it said in a statement. It will also upgrade the Anglo-Swedish drugmaker's U.S. clinical trial supply network and support ongoing investment in novel medicines. On Monday, AstraZeneca said the expansion supports its ambition to reach $80 billion in annual revenue by 2030, with half coming from the U.S. The U.S. accounted for more than 40% of AstraZeneca's annual revenue in 2024, and the company had been prioritising the market - the world's largest, worth $635 billion - before Trump's return to office. The move to scale up its U.S. footprint is the latest by a drugmaker as Trump threatens to impose import tariffs on the industry and seeks to boost domestic manufacturing. The sector has historically been spared from trade disputes. Trump has called on pharma companies to make more of the medicines they sell in the U.S. within the country, rather than importing active ingredients or finished medicines. He is also pushing for prices in the U.S. to fall to what other countries pay. CEO Pascal Soriot announced the plans in Washington, saying he believes that drug prices need to rise elsewhere and "equalize" with other countries effectively contributing more to research and development costs. "The United States cannot build or carry the cost of R&D for the entire world," he said. U.S. Commerce Secretary Howard Lutnick's department is leading a probe into pharmaceutical imports that could pave the way for new tariffs. "For decades Americans have been reliant on foreign supply of key pharmaceutical products. President Trump and our nation's new tariff policies are focused on ending this structural weakness," said Lutnick in a statement issued by AstraZeneca. While Trump has repeatedly threatened tariffs on the sector, he signalled earlier this month that companies would be given a year to 18 months to "get their act together" before any levies take effect. The company said that the timing and location of the announcement was linked to the U.S. policy environment, though some of the spending would have occurred regardless so that the infrastructure for future medicines was in place. The pledge is in addition to the $3.5 billion in investments the company announced in November 2024, the statement said. PLEDGES The $50 billion pledge matches the commitment announced by Swiss rival Roche in April and follows new spending plans unveiled this year by Eli Lilly & Co, Johnson & Johnson , Novartis, and Sanofi. Also present at the announcement was Virginia State Governor Glenn Youngkin, a vocal Trump ally who has defended the administration's tariff policies. The new Virginia facility - the company's largest single manufacturing investment - will produce active ingredients for AstraZeneca's experimental weight-loss medicines, including its oral GLP-1 candidate and an oral PCSK9 inhibitor for cholesterol management, it said. The company said the investment could create tens of thousands of new jobs, but declined to give specifics. It employs about 18,000 people in the U.S. and has a global workforce of about 90,000. In January it scrapped plans to invest 450 million pounds ($607.1 million) in its vaccine manufacturing plant in northern England, citing a cut in government support. Earlier this month, The Times reported the company was considering moving its stock market listing from London, where it is the exchange's most valuable company worth 159 billion pounds, to the U.S. The company declined to comment.


NDTV
19 minutes ago
- NDTV
US Department Of Justice Wants To Interview Jeffrey Epstein's Ex-Girlfriend Ghislaine Maxwell
The US Department of Justice is seeking to interview Ghislaine Maxwell, the imprisoned accomplice of sex offender Jeffrey Epstein, officials said Tuesday, as President Donald Trump struggles to quell a furor over the handling of the explosive case. The former British socialite is currently serving a 20-year sentence after being convicted in 2021 of sex trafficking minors on behalf of Epstein, who died in jail in 2019 while awaiting trial in his own pedophile trafficking case. "President Trump has told us to release all credible evidence" about the Epstein case, Deputy Attorney General Todd Blanche said in a statement on X. The surprise announcement marked the Trump administration's latest effort to defuse spiraling anger among the Republican's own supporters over what they have long seen as a cover-up of Epstein's crimes and high-level connections. Blanche said an FBI review of the evidence against Epstein -- a wealthy financier whose powerful friends once included Trump -- had found nothing to suggest new leads. But if Maxwell "has information about anyone who has committed crimes against victims, the FBI and the DOJ will hear what she has to say," said Blanche, who was formerly Trump's personal lawyer. "No one is above the law -- and no lead is off-limits." David Oscar Markus, Maxwell's lawyer, confirmed on X that he was in discussions with the government and said "Ghislaine will always testify truthfully." "We are grateful to President Trump for his commitment to uncovering the truth in this case," Markus added. Maxwell is the only former Epstein associate who was convicted in connection with his activities, which right-wing conspiracy theorists allege included trafficking young models for VIPs. Trump's conspiracy-minded supporters have been obsessed with the Epstein case for years and have been up in arms since the FBI and Justice Department said on July 7 that Epstein had committed suicide while in jail, did not blackmail any prominent figures, and did not keep a "client list." Trump has tried a variety of measures to placate his base, including by ordering Attorney General Pam Bondi to try to obtain release of grand jury testimony in Epstein's aborted New York case. At a White House meeting with the Philippine's president on Tuesday, Trump dismissed the entire Epstein scandal as "a witch hunt." Epstein Prosecutor Fired However, the president's MAGA (Make America Great Again) movement has long held as an article of faith that "Deep State" elites were protecting Epstein's associates in the Democratic Party and Hollywood -- although not Trump himself. While no evidence has emerged of any wrongdoing by Trump, the president had a close friendship with Epstein and he sued the Wall Street Journal last week after it published a story about a raunchy letter he purportedly sent to Epstein for his 50th birthday. The latest developments come just days after the federal prosecutor who handled Epstein's and Maxwell's sex trafficking cases was abruptly fired by the Trump Justice Department. Maurene Comey -- the daughter of former FBI director James Comey, a prominent Trump critic -- was dismissed on July 16 from her position as an assistant US attorney in Manhattan. The furor over Epstein has derailed business in the US House of Representatives, where Speaker Mike Johnson is sending lawmakers home early to derail demands by Democrats for a vote to release the "Epstein files." Epstein was found hanging dead in his New York prison cell while awaiting trial on charges that he sexually exploited dozens of underage girls at his homes in New York and Florida. The FBI and New York medical examiner ruled his death a suicide but the determination has done little to quell speculation in right-wing circles that he was murdered. Among those with connections to Epstein was Britain's Prince Andrew, who settled a US civil case in February 2022 brought by Virginia Giuffre, who claimed he sexually assaulted her when she was 17. Giuffre, who accused Epstein of using her as a sex slave, committed suicide at her home in Australia in April. Billionaire Elon Musk accused President Donald Trump on X last month of being in the "Epstein files" after the pair had a falling out, but he later deleted his posts. (Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)